Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.168 Q1 | 93 | 156 | 307 | 20941 | 1937 | 293 | 5.01 | 134.24 | |
2 | Current Vascular Pharmacology | journal | 0.917 Q1 | 67 | 60 | 187 | 4056 | 702 | 153 | 3.86 | 67.60 | |
3 | Current Medicinal Chemistry | journal | 0.776 Q2 | 192 | 335 | 1214 | 38296 | 5194 | 1130 | 3.90 | 114.32 | |
4 | Current Molecular Pharmacology | journal | 0.694 Q2 | 46 | 71 | 166 | 7930 | 515 | 157 | 2.65 | 111.69 | |
5 | Current Cancer Drug Targets | journal | 0.687 Q2 | 99 | 69 | 228 | 5875 | 723 | 219 | 2.95 | 85.14 | |
6 | Current Drug Targets | journal | 0.621 Q2 | 112 | 110 | 419 | 12345 | 1440 | 403 | 3.13 | 112.23 | |
7 | Current Pharmaceutical Design | journal | 0.580 Q2 | 176 | 329 | 1399 | 30191 | 4651 | 1281 | 2.99 | 91.77 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 0.574 Q2 | 93 | 81 | 217 | 8156 | 634 | 205 | 2.87 | 100.69 | |
9 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q2 | 101 | 162 | 449 | 17321 | 1935 | 442 | 4.02 | 106.92 | |
10 | Current Gene Therapy | journal | 0.564 Q2 | 78 | 36 | 122 | 3105 | 436 | 107 | 3.32 | 86.25 | |
11 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q2 | 48 | 35 | 97 | 3255 | 293 | 92 | 2.65 | 93.00 | |
12 | Current Topics in Medicinal Chemistry | journal | 0.516 Q2 | 127 | 191 | 680 | 18928 | 1968 | 550 | 2.77 | 99.10 | |
13 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.428 Q3 | 103 | 286 | 635 | 21787 | 1755 | 622 | 2.77 | 76.18 | |
14 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.406 Q2 | 45 | 26 | 99 | 1407 | 188 | 94 | 1.74 | 54.12 | |
15 | Current Drug Delivery | journal | 0.391 Q2 | 68 | 87 | 292 | 5415 | 900 | 280 | 2.54 | 62.24 | |
16 | Current Radiopharmaceuticals | journal | 0.379 Q3 | 30 | 38 | 99 | 1789 | 183 | 87 | 1.69 | 47.08 | |
17 | Reviews on Recent Clinical Trials | journal | 0.377 Q3 | 34 | 46 | 136 | 1902 | 224 | 119 | 1.58 | 41.35 | |
18 | Open Medicinal Chemistry Journal | journal | 0.352 Q2 | 21 | 6 | 22 | 464 | 51 | 19 | 2.75 | 77.33 | |
19 | Recent Advances in Drug Delivery and Formulation | journal | 0.347 Q3 | 38 | 23 | 58 | 1876 | 139 | 52 | 1.72 | 81.57 | |
20 | Current Drug Discovery Technologies | journal | 0.329 Q3 | 46 | 40 | 194 | 2318 | 391 | 189 | 1.68 | 57.95 | |
21 | Medicinal Chemistry | journal | 0.324 Q3 | 48 | 83 | 270 | 4451 | 599 | 264 | 2.19 | 53.63 | |
22 | Current Drug Safety | journal | 0.318 Q3 | 39 | 55 | 117 | 1784 | 172 | 113 | 1.47 | 32.44 | |
23 | Infectious Disorders - Drug Targets | journal | 0.298 Q3 | 59 | 100 | 328 | 4928 | 479 | 311 | 1.40 | 49.28 | |
24 | Current Nanoscience | journal | 0.284 Q3 | 51 | 64 | 236 | 5132 | 379 | 228 | 1.58 | 80.19 | |
25 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.280 Q3 | 26 | 18 | 87 | 1262 | 143 | 82 | 1.41 | 70.11 | |
26 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.277 Q3 | 35 | 20 | 41 | 763 | 82 | 36 | 1.30 | 38.15 | |
27 | Combinatorial Chemistry and High Throughput Screening | journal | 0.271 Q3 | 68 | 227 | 359 | 11783 | 568 | 333 | 1.66 | 51.91 | |
28 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q3 | 44 | 29 | 106 | 1316 | 122 | 100 | 1.08 | 45.38 | |
29 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.268 Q3 | 42 | 26 | 55 | 1492 | 97 | 49 | 1.37 | 57.38 | |
30 | Current Computer-Aided Drug Design | journal | 0.258 Q3 | 31 | 42 | 195 | 1983 | 320 | 187 | 1.73 | 47.21 | |
31 | Drug Metabolism Letters | journal | 0.241 Q3 | 31 | 1 | 38 | 0 | 51 | 36 | 1.17 | 0.00 | |
32 | Current Bioactive Compounds | journal | 0.207 Q3 | 29 | 79 | 280 | 4374 | 311 | 272 | 1.00 | 55.37 | |
33 | Letters in Drug Design and Discovery | journal | 0.192 Q3 | 36 | 89 | 355 | 4304 | 370 | 329 | 1.08 | 48.36 | |
34 | Current Pharmaceutical Analysis | journal | 0.178 Q3 | 26 | 88 | 340 | 4225 | 231 | 335 | 0.66 | 48.01 | |
35 | Current Enzyme Inhibition | journal | 0.174 Q4 | 18 | 22 | 69 | 1028 | 46 | 61 | 0.71 | 46.73 | |
36 | Current Drug Therapy | journal | 0.169 Q3 | 19 | 35 | 114 | 1963 | 80 | 111 | 0.71 | 56.09 | |
37 | Anti-Infective Agents | journal | 0.159 Q4 | 25 | 44 | 125 | 2557 | 91 | 120 | 0.67 | 58.11 | |
38 | Anti-Obesity Drug Discovery and Development | book series | 0.131 Q4 | 1 | 0 | 7 | 0 | 0 | 1 | 0.00 | 0.00 | |
39 | Current Pharmacogenomics and Personalized Medicine | journal | 0.110 Q4 | 20 | 12 | 37 | 381 | 9 | 32 | 0.24 | 31.75 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®